Literature DB >> 32001435

Incidence and economic burden of Clostridioides difficile infection in Ontario: a retrospective population-based study.

Jennifer A Pereira1, Allison McGeer2, Antigona Tomovici2, Alex Selmani2, Ayman Chit2.   

Abstract

BACKGROUND: Understanding the impact of prevention programs on Clostridioides difficile infection rates is important, and decisions on future program changes, including how to use vaccines currently in development, requires a detailed understanding of the epidemiologic features of C. difficile infection. We analyzed Ontario health administrative data to determine incidence rates and medical costs of C. difficile infection, based on whether acquisition and onset occurred in acute care hospitals (ACHs), long-term care facilities or the community.
METHODS: We performed a retrospective analysis using individual-level data from Ontario health databases from Apr. 1, 2005, to Mar. 31, 2015, identifying rates of C. difficile infection requiring hospital admission per 100 000 person-years in adults aged 18 years or more for categories of acquisition and onset. We estimated health care system costs of infection 180 and 365 days after admission by matching patients with C. difficile infection with control patients with similar characteristics.
RESULTS: Over the study period, 33 909 people in Ontario were admitted to hospital with C. difficile infection; 17 272 cases (50.9%) were associated with ACHs. The number of cases per 100 000 person-years ranged from 27.7 in 2009/10 to 37.0 in 2012/13. Annually, the highest incidence of infection was for ACH-associated/ACH-onset. Community-associated infection became more prevalent over time, rising from 19.4% of cases in 2005/06 to 29.2% in 2014/15. Infection costs were mostly due to hospital admission within 180 days after hospital discharge. Infection associated with ACHs had the highest total costs and the largest cost attributable to C. difficile infection (median $38 953 for infected patients v. $13 542 for control patients). Median costs attributable to C. difficile infection were $1051 for that associated with long-term care facilities, $13 249 for community-associated infection and $11 917 for ACH-associated/community-onset infection.
INTERPRETATION: Community-associated C. difficile infection had similar health care cost implications as hospital-associated infection. With rates of community-associated C. difficile infection on the rise, family physicians should be supported to prevent this infection in their patients. Copyright 2020, Joule Inc. or its licensors.

Entities:  

Mesh:

Year:  2020        PMID: 32001435      PMCID: PMC7004222          DOI: 10.9778/cmajo.20190018

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  28 in total

Review 1.  Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review.

Authors:  Andrew E Simor
Journal:  J Am Geriatr Soc       Date:  2010-07-14       Impact factor: 5.562

2.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

Authors:  Vivian G Loo; Louise Poirier; Mark A Miller; Matthew Oughton; Michael D Libman; Sophie Michaud; Anne-Marie Bourgault; Tuyen Nguyen; Charles Frenette; Mirabelle Kelly; Anne Vibien; Paul Brassard; Susan Fenn; Ken Dewar; Thomas J Hudson; Ruth Horn; Pierre René; Yury Monczak; André Dascal
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

3.  A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data.

Authors:  Carl van Walraven; Peter C Austin; Alison Jennings; Hude Quan; Alan J Forster
Journal:  Med Care       Date:  2009-06       Impact factor: 2.983

4.  Infection control practices related to Clostridium difficile infection in acute care hospitals in Canada.

Authors:  Denise Gravel; Michael Gardam; Geoffrey Taylor; Mark Miller; Andrew Simor; Allison McGeer; James Hutchinson; Dorothy Moore; Sharon Kelly; Michael Mulvey
Journal:  Am J Infect Control       Date:  2009-02       Impact factor: 2.918

5.  The epidemiology of community-acquired Clostridium difficile infection: a population-based study.

Authors:  Sahil Khanna; Darrell S Pardi; Scott L Aronson; Patricia P Kammer; Robert Orenstein; Jennifer L St Sauver; W Scott Harmsen; Alan R Zinsmeister
Journal:  Am J Gastroenterol       Date:  2011-11-22       Impact factor: 10.864

6.  Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011-2015.

Authors:  Alice Y Guh; Yi Mu; James Baggs; Lisa G Winston; Wendy Bamberg; Carol Lyons; Monica M Farley; Lucy E Wilson; Stacy M Holzbauer; Erin C Phipps; Zintars G Beldavs; Marion A Kainer; Maria Karlsson; Dale N Gerding; Ghinwa Dumyati
Journal:  Am J Infect Control       Date:  2018-01-09       Impact factor: 2.918

7.  Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.

Authors:  M H Wilcox; N Shetty; W N Fawley; M Shemko; P Coen; A Birtles; M Cairns; M D Curran; K J Dodgson; S M Green; K J Hardy; P M Hawkey; J G Magee; A D Sails; M W D Wren
Journal:  Clin Infect Dis       Date:  2012-07-11       Impact factor: 9.079

8.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Authors:  Jacques Pépin; Louis Valiquette; Marie-Eve Alary; Philippe Villemure; Annick Pelletier; Karine Forget; Karine Pépin; Daniel Chouinard
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

9.  The impact of infection on population health: results of the Ontario burden of infectious diseases study.

Authors:  Jeffrey C Kwong; Sujitha Ratnasingham; Michael A Campitelli; Nick Daneman; Shelley L Deeks; Douglas G Manuel; Vanessa G Allen; Ahmed M Bayoumi; Aamir Fazil; David N Fisman; Andrea S Gershon; Effie Gournis; E Jenny Heathcote; Frances B Jamieson; Prabhat Jha; Kamran M Khan; Shannon E Majowicz; Tony Mazzulli; Allison J McGeer; Matthew P Muller; Abhishek Raut; Elizabeth Rea; Robert S Remis; Rita Shahin; Alissa J Wright; Brandon Zagorski; Natasha S Crowcroft
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

10.  Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes.

Authors:  Jennifer C Hunter; Yi Mu; Ghinwa K Dumyati; Monica M Farley; Lisa G Winston; Helen L Johnston; James I Meek; Rebecca Perlmutter; Stacy M Holzbauer; Zintars G Beldavs; Erin C Phipps; John R Dunn; Jessica A Cohen; Johannetsy Avillan; Nimalie D Stone; Dale N Gerding; L Clifford McDonald; Fernanda C Lessa
Journal:  Open Forum Infect Dis       Date:  2016-01-18       Impact factor: 3.835

View more
  6 in total

1.  The Economic Burden of Clostridioides difficile in Denmark: A Retrospective Cohort Study.

Authors:  Uffe Christian Braae; Frederik Trier Møller; Rikke Ibsen; Steen Ethelberg; Jakob Kjellberg; Kåre Mølbak
Journal:  Front Public Health       Date:  2020-11-26

2.  Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients.

Authors:  Seyed M Hosseini-Moghaddam; Bin Luo; Sarah E Bota; Shahid Husain; Michael S Silverman; Nick Daneman; Kevin A Brown; J Michael Paterson
Journal:  JAMA Netw Open       Date:  2021-12-01

3.  Did the severe acute respiratory syndrome-coronavirus 2 pandemic cause an endemic Clostridium difficile infection?

Authors:  Camelia Cojocariu; Irina Girleanu; Anca Trifan; Andrei Olteanu; Cristina Maria Muzica; Laura Huiban; Stefan Chiriac; Ana Maria Singeap; Tudor Cuciureanu; Catalin Sfarti; Carol Stanciu
Journal:  World J Clin Cases       Date:  2021-11-26       Impact factor: 1.337

4.  Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015-2019.

Authors:  Tim Du; Kelly B Choi; Anada Silva; George R Golding; Linda Pelude; Romeo Hizon; Ghada N Al-Rawahi; James Brooks; Blanda Chow; Jun C Collet; Jeannette L Comeau; Ian Davis; Gerald A Evans; Charles Frenette; Guanghong Han; Jennie Johnstone; Pamela Kibsey; Kevin C Katz; Joanne M Langley; Bonita E Lee; Yves Longtin; Dominik Mertz; Jessica Minion; Michelle Science; Jocelyn A Srigley; Paula Stagg; Kathryn N Suh; Nisha Thampi; Alice Wong; Susy S Hota
Journal:  Emerg Infect Dis       Date:  2022-04-26       Impact factor: 16.126

Review 5.  Epidemiology of community-acquired and recurrent Clostridioides difficile infection.

Authors:  Yichun Fu; Yuying Luo; Ari M Grinspan
Journal:  Therap Adv Gastroenterol       Date:  2021-05-22       Impact factor: 4.409

6.  Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile Infection: Systematic Review and Meta-analysis.

Authors:  Yi Nong Song; David Yi Yang; Sander Veldhuyzen van Zanten; Karen Wong; Eric McArthur; Claire Zhao Song; Gianluca Ianiro; Giovanni Cammarota; Colleen Kelly; Monika Fischer; Lindsey Russell; Dina Kao
Journal:  J Can Assoc Gastroenterol       Date:  2021-07-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.